Clinical Trial Update: INtensive liPid-lowering Therapy for Acute High-risk IntracRanial or Extracranial atheroSclerosis -II (INSPIRES-2) [NA]

View source ↗

Summary

Clinical trial INSPIRES-2 is evaluating intensive lipid-lowering therapy for acute high-risk intracranial or extracranial atherosclerosis. The study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke or High-risk TIA (ABCD² ≥ 4) | NA | Status: NOT_YET_RECRUITING